When.com Web Search

  1. Ads

    related to: which medication is an antifungal agent

Search results

  1. Results From The WOW.Com Content Network
  2. Antifungal - Wikipedia

    en.wikipedia.org/wiki/Antifungal

    An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.

  3. Topical antifungal - Wikipedia

    en.wikipedia.org/wiki/Topical_antifungal

    The general mechanism of action for topical antifungal drugs is the disruption of the cell membrane. The unique components found in fungal cell membranes are usually the drug targets of antifungal drugs, in particular ergosterol. It is a sterol, which is important in maintaining proper membrane fluidity and normal functions of the cell membrane.

  4. Fungistatics - Wikipedia

    en.wikipedia.org/wiki/Fungistatics

    Itraconazole (R51211), invented in 1984, is a triazole fungistatic antifungal agent prescribed to patients with fungal infections. The drug may be given orally or intravenously. Itraconazole has a broader spectrum of activity than fluconazole (but not as broad as voriconazole or posaconazole).

  5. Amphotericin B - Wikipedia

    en.wikipedia.org/wiki/Amphotericin_B

    Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. [3] ... This is amphotericin B's primary effect as an antifungal agent.

  6. Nystatin - Wikipedia

    en.wikipedia.org/wiki/Nystatin

    Nystatin, sold under the brand name Mycostatin among others, is an antifungal medication. [1] It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. [1] It may also be used to prevent candidiasis in those who are at high risk. [1]

  7. Fluconazole - Wikipedia

    en.wikipedia.org/wiki/Fluconazole

    Antifungal resistance to drugs in the azole class tends to occur gradually over the course of prolonged drug therapy, resulting in clinical failure in immunocompromised patients (e.g., patients with advanced HIV receiving treatment for thrush or esophageal Candida infection).